Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Nefrología (English Edition)Open Access

Assessment and prediction of diabetic kidney disease in patients with type 2 diabetes mellitus by using an advanced biomarkers

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAlyaa HlielHAHuda Al Sayed AhmedHHHiba Ali Hasan

Discussion

Loading...

Member takes

Overview

Case-control study highlights the role of MCP-1 and WISP1 in diagnosing diabetic kidney disease.

Key Points

  • The study identifies MCP-1 as a strong predictor for diabetic kidney disease diagnosis.
  • MCP-1 showed 100% specificity in proteinuria detection, making it a valuable diagnostic biomarker.
  • Analyzing urinary albumin/creatinine ratio revealed significant differences in renal function across diabetes stages.
  • Both MCP-1 and WISP1 levels were significantly elevated in type 2 diabetes mellitus patients compared to healthy controls.

Cite This Study

Hliel et al. (2025) studied this question.

synapsesocial.com/papers/68c24236b210217d647a2347https://doi.org/10.1016/j.nefroe.2025.101330
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of novel biomarkers urinary NGAL and MCP-1 in predicting progression of diabetic kidney disease in type 2 DM2025 · 5 citations
  2. 2A novel biomarker Ins60/ApoA for predicting diabetic kidney disease in newly diagnosed type 2 diabetes: a pilot study2025
  3. 3Analysing The Diagnostic Value Of Microalbuminuria As A Bio-Marker For Diabetic Nephropathy By Correlating With Fasting Blood Sugar, Serum Creatinine And Hba1c In Type 2 Diabetes Mellitus: A Case-Control Study2025
  4. 4Plasma levels of the lymphangiogenic factors VEGF-C, VEGF-D, and CXCL-12 are elevated in advanced diabetic nephropathy2025
  5. 5Study of Cystatin C and Renal Resistive Index in Type 2 Diabetes Mellitus Patients to Detect Early Diabetic Kidney Disease2025